Opening GPAtlas…

🌊 The Ocean Library · GP clinical topic

Serotonin Syndrome

Reviewed and updated by practising UK GPs, overseen by our Clinical Advisory Officer.

🧭 When to suspect

Serotonin syndrome (serotonin toxicity) is a potentially life-threatening, drug-induced reaction caused by excess serotonergic activity in the central nervous system.

• It is defined by a clinical triad of altered mental state, autonomic hyperactivity and neuromuscular excitation.

• It spans a dose-related spectrum from mild, self-limiting effects through to fatal toxicity.

• It can follow a single drug at a therapeutic dose, but most cases arise from a combination of serotonergic drugs, a recent dose increase, or an overdose.

Onset is characteristically rapid:

• Features usually appear within 24 hours, and about 60% within 6 hours, of starting, increasing or combining a serotonergic drug.

• Severe, life-threatening toxicity (rigidity and hyperthermia) almost always requires two or more serotonergic agents, one of which is often a monoamine oxidase inhibitor (MAOI).

Think of it in any patient on a serotonergic drug with new neuromuscular signs, examine for clonus, and diagnose using the Hunter Serotonin Toxicity Criteria rather than waiting for the full triad.

Severity Typical features Action
Mild

• Tachycardia, shivering, diaphoresis, mydriasis, tremor, mild hyperreflexia

• Afebrile and haemodynamically stable

Often manageable in the community: stop the agent, supportive care, review – with a low threshold to refer
Moderate Above plus inducible/ocular clonus, agitation, marked hyperreflexia, temperature up to ~40°C, hypertension Emergency hospital assessment
Severe Spontaneous/sustained clonus, truncal rigidity, hyperthermia > 41°C, autonomic instability, delirium or reduced consciousness

• 999 – life-threatening

• Requires intensive care

Drug group Common UK examples (brands)
SSRIs/SNRIs

• Sertraline (Lustral), fluoxetine (Prozac), citalopram, escitalopram, paroxetine (Seroxat)

• Venlafaxine (Efexor), duloxetine (Cymbalta)

MAOIs (incl. "hidden")

• Phenelzine (Nardil), tranylcypromine, isocarboxazid, moclobemide (Manerix)

• The antibiotic linezolid (Zyvox) and methylene blue

Opioids

• Tramadol (Zydol), pethidine, fentanyl, methadone

• Dextromethorphan

Other prescribed

• Triptans e.g. sumatriptan (Imigran)

• Lithium

• Tricyclics e.g. clomipramine (Anafranil)

• Mirtazapine

• Ondansetron/metoclopramide (weak)

OTC/recreational

• St John's wort

• MDMA ("ecstasy"), amphetamines, cocaine

Source: Hunter Criteria · BMJ (Isbister, 2014)


🔒 Sign up free to read the full topic

You're viewing a free preview. Create a free account to unlock the rest.

Sign up free →
Inside the full topic 🔒 History🔒 Red Flags🔒 Examination🔒 Patient Explanation🔒 Investigations🔒 Management🔒 Non-pharmacological Treatment🔒 Pharmacological Treatment🔒 Special Notes🔒 Referral Pathways🔒 Take Home Messages

Sample topics are open to everyone in the Free Sample Bundle.

Part of The Ocean Library, 450+ structured clinical topics mapped to the primary care curriculum. Companion audio in Echo · one-page summary in The Scope.

We use cookies to enhance your browsing experience, provide personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Privacy policy